Australia Non-alcoholic Steatohepatitis Market (2025-2031) | Trends, Outlook, Segmentation, Competitive Landscape, Analysis, Companies, Size & Revenue, Value, Industry, Growth, Share, Forecast

Name: Australia Non-alcoholic Steatohepatitis Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, Obeticholic Acid, Others), By Sales Channel (Hospital Pharmacy, Online Providers, Retail Pharmacy), By Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), By End User (Hospitals, Clinics, Homecare settings) And Competitive Landscape

Product Code: ETC6186370	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Shubham Deep	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Australia Non Alcoholic Steatohepatitis Market Overview

The non-alcoholic steatohepatitis (NASH) market in Australia is growing due to increasing cases of obesity and metabolic syndrome. Pharmaceutical treatments and lifestyle interventions are driving the market as awareness about liver health increases.

Drivers of the market

The non-alcoholic steatohepatitis market in Australia is driven by increasing cases of obesity, type 2 diabetes, and metabolic syndrome. Rising investment in drug development, increasing availability of diagnostic tools, and growing awareness about liver health are fueling market growth. Government support for clinical trials and increasing demand for combination therapies are also supporting market expansion.

Challenges of the market

The non-alcoholic steatohepatitis (NASH) market in Australia faces challenges from high drug development and clinical trial costs. Regulatory requirements for drug safety and efficacy increase market entry barriers. Limited awareness among healthcare providers and patients reduces market demand. High treatment costs and limited government reimbursement further restrict market expansion.

Investment opportunities in the Market

The non-alcoholic steatohepatitis (NASH) market in Australia is expanding due to increasing obesity and diabetes rates. NASH is a severe form of fatty liver disease with limited treatment options. Investment opportunities lie in developing new drug therapies, improving diagnostic capabilities, and expanding patient access to specialized healthcare services. Growth in liver health awareness and government support for metabolic disease research are driving market growth.

Government Policy of the market

Non-alcoholic steatohepatitis (NASH) treatments, including drugs and lifestyle programs, are regulated by the TGA. The PBS covers certain medications used to manage NASH. The government funds research into liver diseases through the MRFF. Public health campaigns focus on raising awareness about obesity and metabolic syndrome, which are key drivers of NASH. Import and export of NASH medications are controlled under pharmaceutical trade laws.

Key Highlights of the Report:

Australia Non-alcoholic Steatohepatitis Market Outlook
Market Size of Australia Non-alcoholic Steatohepatitis Market, 2024
Forecast of Australia Non-alcoholic Steatohepatitis Market, 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Revenues & Volume for the Period 2021- 2031
Australia Non-alcoholic Steatohepatitis Market Trend Evolution
Australia Non-alcoholic Steatohepatitis Market Drivers and Challenges
Australia Non-alcoholic Steatohepatitis Price Trends
Australia Non-alcoholic Steatohepatitis Porter's Five Forces
Australia Non-alcoholic Steatohepatitis Industry Life Cycle
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Drug Type for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Vitamin E and Pioglitazone for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Ocaliva for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Elafibranor for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Selonsertib and Cenicriviroc for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Obeticholic Acid for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Sales Channel for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Online Providers for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Disease Cause for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Hypertension for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Heart Disease for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By High Blood Lipid for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Type 2 Diabetes for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Obesity for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By End User for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Clinics for the Period 2021- 2031
Historical Data and Forecast of Australia Non-alcoholic Steatohepatitis Market Revenues & Volume By Homecare settings for the Period 2021- 2031
Australia Non-alcoholic Steatohepatitis Import Export Trade Statistics
Market Opportunity Assessment By Drug Type
Market Opportunity Assessment By Sales Channel
Market Opportunity Assessment By Disease Cause
Market Opportunity Assessment By End User
Australia Non-alcoholic Steatohepatitis Top Companies Market Share
Australia Non-alcoholic Steatohepatitis Competitive Benchmarking By Technical and Operational Parameters
Australia Non-alcoholic Steatohepatitis Company Profiles
Australia Non-alcoholic Steatohepatitis Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Australia Non-alcoholic Steatohepatitis Market Overview

3.1 Australia Country Macro Economic Indicators

3.2 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, 2021 & 2031F

3.3 Australia Non-alcoholic Steatohepatitis Market - Industry Life Cycle

3.4 Australia Non-alcoholic Steatohepatitis Market - Porter's Five Forces

3.5 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F

3.7 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Disease Cause, 2021 & 2031F

3.8 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By End User, 2021 & 2031F

4 Australia Non-alcoholic Steatohepatitis Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of obesity and diabetes in Australia leading to a higher incidence of non-alcoholic steatohepatitis (NASH).

4.2.2 Growing awareness among healthcare professionals and patients about the consequences of untreated NASH.

4.2.3 Technological advancements in diagnostic tools and treatment options for NASH.

4.3 Market Restraints

4.3.1 Limited availability of approved treatments specific to NASH in Australia.

4.3.2 High cost associated with NASH diagnosis and treatment.

4.3.3 Lack of standardized guidelines for the management of NASH in Australia.

5 Australia Non-alcoholic Steatohepatitis Market Trends

6 Australia Non-alcoholic Steatohepatitis Market, By Types

6.1 Australia Non-alcoholic Steatohepatitis Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F

6.1.4 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Ocaliva, 2021- 2031F

6.1.5 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Elafibranor, 2021- 2031F

6.1.6 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Selonsertib and Cenicriviroc, 2021- 2031F

6.1.7 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obeticholic Acid, 2021- 2031F

6.1.8 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Others, 2021- 2031F

6.2 Australia Non-alcoholic Steatohepatitis Market, By Sales Channel

6.2.1 Overview and Analysis

6.2.2 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.2.3 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Online Providers, 2021- 2031F

6.2.4 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3 Australia Non-alcoholic Steatohepatitis Market, By Disease Cause

6.3.1 Overview and Analysis

6.3.2 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hypertension, 2021- 2031F

6.3.3 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Heart Disease, 2021- 2031F

6.3.4 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By High Blood Lipid, 2021- 2031F

6.3.5 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F

6.3.6 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obesity, 2021- 2031F

6.4 Australia Non-alcoholic Steatohepatitis Market, By End User

6.4.1 Overview and Analysis

6.4.2 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Australia Non-alcoholic Steatohepatitis Market Revenues & Volume, By Homecare settings, 2021- 2031F

7 Australia Non-alcoholic Steatohepatitis Market Import-Export Trade Statistics

7.1 Australia Non-alcoholic Steatohepatitis Market Export to Major Countries

7.2 Australia Non-alcoholic Steatohepatitis Market Imports from Major Countries

8 Australia Non-alcoholic Steatohepatitis Market Key Performance Indicators

8.1 Percentage increase in the number of NASH diagnoses annually.

8.2 Adoption rate of new diagnostic tools for NASH in clinical settings.

8.3 Patient adherence rate to prescribed treatment regimens for NASH.

9 Australia Non-alcoholic Steatohepatitis Market - Opportunity Assessment

9.1 Australia Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 Australia Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Sales Channel, 2021 & 2031F

9.3 Australia Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Disease Cause, 2021 & 2031F

9.4 Australia Non-alcoholic Steatohepatitis Market Opportunity Assessment, By End User, 2021 & 2031F

10 Australia Non-alcoholic Steatohepatitis Market - Competitive Landscape

10.1 Australia Non-alcoholic Steatohepatitis Market Revenue Share, By Companies, 2024

10.2 Australia Non-alcoholic Steatohepatitis Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Non-Alcoholic Steatohepatitis Market

Argentina Non-alcoholic Steatohepatitis Market

Brazil Non-alcoholic Steatohepatitis Market

Cambodia Non-alcoholic Steatohepatitis Market

Chile Non-alcoholic Steatohepatitis Market

China Non-alcoholic Steatohepatitis Market

Europe Non-Alcoholic Steatohepatitis Market

Global Non-alcoholic Steatohepatitis Market

Middle East Non-Alcoholic Steatohepatitis Market

North America Non-Alcoholic Steatohepatitis Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here